Steven A Feldman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Steven A Feldman

Showing results (11-20 of 70) with videos related to

Pageof 7

Sort By:

Journal of Translational Medicine|January 26, 2018

Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modulesJianjian Jin, Nikolaos Gkitsas, Vicki S Fellowes, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2020

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7Christina Amatya, Melissa A Pegues, Norris Lam, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptorJames N Kochenderfer, Steven A Feldman, Yangbing Zhao, et al.

Human Gene Therapy Methods|July 30, 2014

Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectorsSteven A Feldman, Hui Xu, Mary A Black, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012

Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical applicationLing Zhang, Steven A Feldman, Zhili Zheng, et al.

The Journal of Clinical Investigation|October 28, 2010

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in miceDhanalakshmi Chinnasamy, Zhiya Yu, Marc R Theoret, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2025

Automated manufacturing of cell therapiesAlice Melocchi, Brigitte Schmittlein, Sudeshna Sadhu, et al.

Blood Cancer Discovery|September 27, 2021

Scalable Manufacturing of CAR T cells for Cancer ImmunotherapyMohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, et al.

Cancer Immunology, Immunotherapy : CII|July 15, 2010

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionStephanie L Goff, Laura A Johnson, Mary A Black, et al.

Cancer Research|April 17, 2010

A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomasWilliam R Burns, Yangbing Zhao, Timothy L Frankel, et al.

Pageof 7

Search research articles

Showing results (11-20 of 70) with videos related to

Sort By:

Pageof 7

Journal of Translational Medicine|January 26, 2018

Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modulesJianjian Jin, Nikolaos Gkitsas, Vicki S Fellowes, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2020

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7Christina Amatya, Melissa A Pegues, Norris Lam, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptorJames N Kochenderfer, Steven A Feldman, Yangbing Zhao, et al.

Human Gene Therapy Methods|July 30, 2014

Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectorsSteven A Feldman, Hui Xu, Mary A Black, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012

Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical applicationLing Zhang, Steven A Feldman, Zhili Zheng, et al.

The Journal of Clinical Investigation|October 28, 2010

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in miceDhanalakshmi Chinnasamy, Zhiya Yu, Marc R Theoret, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2025

Automated manufacturing of cell therapiesAlice Melocchi, Brigitte Schmittlein, Sudeshna Sadhu, et al.

Blood Cancer Discovery|September 27, 2021

Scalable Manufacturing of CAR T cells for Cancer ImmunotherapyMohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, et al.

Cancer Immunology, Immunotherapy : CII|July 15, 2010

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionStephanie L Goff, Laura A Johnson, Mary A Black, et al.

Cancer Research|April 17, 2010

A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomasWilliam R Burns, Yangbing Zhao, Timothy L Frankel, et al.

Pageof 7